sevelamer carbonate sanofi sevelamer carbonate 2.4 g powder for oral suspension sachet
sanofi-aventis australia pty ltd - sevelamer carbonate -
sevelamer carbonate sanofi sevelamer carbonate 800 mg tablet bottle
sanofi-aventis australia pty ltd - sevelamer carbonate -
sevelamer carbonate sanofi sevelamer carbonate 1.6 g powder for oral suspension sachet
sanofi-aventis australia pty ltd - sevelamer carbonate -
lixisenatide sanofi treatment initiation pack 10mcg (0.05 mg/ml) and 20 mcg (0.1) mg/ml solution for injection injector pen
sanofi-aventis australia pty ltd - lixisenatide -
teriflunomide sanofi teriflunomide 14 mg film-coated tablets blister pack
sanofi-aventis australia pty ltd - teriflunomide -
danol 200
sanofi - aventis israel ltd - danazol - capsules - danazol 200 mg - danazol - treatment of endometriosis amenable to hormonal management, hereditary angioedema.
jevtana
sanofi israel ltd - cabazitaxel - concentrate and solvent for solution for infusion - cabazitaxel 60 mg / 1.5 ml - cabazitaxel - cabazitaxel - jevtana is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel- containing treatment regimen.
hexaxim
sanofi israel ltd - diphtheria toxoid; filamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; hepatitis b vaccines; pertussis toxoid (pt); poliovirus type 1 inactivated; poliovirus type 2 inactivated; poliovirus type 3 inactivated; tetanus protein conjugate; tetanus toxoid - suspension for injection - diphtheria toxoid; tetanus protein conjugate 22 - 36 mcg / 0.5 ml; haemophilus influenzae type b polysaccharide 12 mcg / 0.5 ml; hepatitis b vaccines 10 mcg / 0.5 ml; poliovirus type 3 inactivated 32 du / 0.5 ml; poliovirus type 2 inactivated 8 du / 0.5 ml; poliovirus type 1 inactivated 40 du / 0.5 ml; filamentous haemagglutinin (fha) 25 mcg / 0.5 ml; pertussis toxoid (pt) 25 mcg / 0.5 ml; tetanus toxoid - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b - hexaxim (dtap-ipv-hb-hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenza type b (hib).the use of this vaccine should be in accordance with official recommendations.
truvelog
sanofi israel ltd - insulin aspart - solution for injection - insulin aspart 100 u/ml - insulin aspart - truvelog is indicated for the treatment of diabetes mellitus in adults.
targocid 200 mg
sanofi - aventis israel ltd - teicoplanin - powder for solution for injection - teicoplanin 200 mg - teicoplanin - teicoplanin - for treatment of potentially serious gram-positive infections including those which cannot be treated with other antimicrobial drugs e.g.penicillins and cephalosporins.